Theravance Biopharma
TBPH
#6351
Rank
C$1.26 B
Marketcap
Country
C$24.42
Share price
0.00%
Change (1 day)
-2.25%
Change (1 year)

EPS for Theravance Biopharma (TBPH)

EPS in 2026 (TTM): C$1.45

According to Theravance Biopharma 's latest financial reports the company's current EPS (TTM) is C$1.52. In 2025 the company made an earnings per share (EPS) of C$3.00 an increase over its 2024 EPS that were of C-$1.65.

EPS history for Theravance Biopharma from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$1.45-51.77%
2025C$3.00-281.74%
2024C-$1.6518.56%
2023C-$1.39-108.41%
2022C$16.55-491.19%
2021C-$4.23-34.15%
2020C-$6.425.16%
2019C-$6.116.5%
2018C-$5.74-26.61%
2017C-$7.8228.24%
2016C-$6.09
2014C-$10.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Corcept Therapeutics
CORT
C$2.15 41.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Collegium Pharmaceutical
COLL
C$1.75 15.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$2.60 70.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
C-$9.08-697.17%๐Ÿ‡บ๐Ÿ‡ธ USA